Allergic reaction cases will be in the vaccine against Moderna’s covid-19 son “raros”, and will be limited to tens of millions of people who receive the first doses in the United States, declaring these women the sanitary authorities.
None of these cases originated during the death of the inoculated person.
“These are preliminary checks, the anaphylactic shocks (severe allergic reaction, ndlr) after the injection of the vaccine of Moderna against the covid-19 are a common event“, a note will be given to the Centers for Prevention and Disappearance (CDC).
The main federal public health agency of study United States, during the period covered between December 21, 2020 and January 10, 108 cases reported with allergic reactions to 4,041,396 first dose injections.
The final evaluations will determine that only these cases have anaphylactic reactions, the six cases are derived in a hospitalization and the other four are treated by the emergency services.
It represents 2.5 anaphylactic reactions per million injections, much less than the Pfizer vaccine, which recorded a level of 11.5 per million inoculations, following an earlier study of the CDC.
Nueve of the 10 affected people have previous allergic reactions, for example drugs or food, but do not administer any vaccine.
The symptoms are manifested in the next 15 minutes after injection in the new cases and the media in the remaining case.
There were thirty women between 31 and 63 years old.
The mayor will also kill some of the people who show allergic reactions to Pfizer’s vaccine, but this could be a source of concern that thirteen women inoculate the first dose of the product of this laboratory belonging to the female sex.
The infrastructures where the vacancies were carried out are conditional on waiting for the severe allergic reactions and transporting them to the hospital patients if necessary, signaling the CDC.